AUTOLOGOUS CHONDROCYTE IMPLANTATION IN BRAZIL

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ATHA COMUNICACAO & EDITORA
Citação
ACTA ORTOPEDICA BRASILEIRA, v.28, n.3, p.131-136, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To describe the first series of cases of autologous chondrocyte implantation (ACI) in collagen membrane performed in Brazil. Methods: ACI was performed in 12 knees of 11 patients, aged 32.1 +/- 10.9 years, with 5.3 +/- 2.6 cm(2) full-thickness knee cartilage lesions, with a six-month minimum follow-up. Two surgical procedures were performed: arthroscopic cartilage biopsy for isolation and expansion of chondrocytes, which were seeded onto collagen membrane and implanted in the lesion site; the characterization of cultured cells and implant was performed using immunofluorescence for type II collagen (COL2) for cell viability and electron microscopy of the implant. Clinical safety, KOOS and IKDC scores and magnetic resonance imaging were evaluated. We used repeated-measures ANOVA and post-hoc comparisons at alpha = 5%. Results: COL2 was identified in the cellular cytoplasm, cell viability was higher than 95% and adequate distribution and cell adhesion were found in the membrane. The median follow-up was 10.9 months (7 to 19). We had two cases of arthrofibrosis, one of graft hypertrophy and one of superficial infection as complications, but none compromising clinical improvement. KOOS and IKDC ranged from 71.2 +/- 11.44 and 50.72 +/- 14.10, in preoperative period, to 85.0 +/- 4.4 and 70.5 +/- 8.0, at 6 months (p = 0.007 and 0.005). MRI showed regenerated tissue compatible with hyaline cartilage. Conclusion: ACI in collagen membrane was feasible and safe in a short-term follow- up, presenting regenerated formation visualized by magnetic resonance imaging and improved clinical function.
Palavras-chave
Cartilage, Cell, and Tissue-Based Therapy, Transplantation, Autologous, Chondrocytes
Referências
  1. [Anonymous], REG ANVISA 806969300
  2. Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
  3. BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
  4. Caldwell KL, 2015, OSTEOARTHR CARTILAGE, V23, P351, DOI 10.1016/j.joca.2014.11.004
  5. Cohen M, 2008, EINSTEIN-SAO PAULO, V6, P37
  6. Ebert JR, 2015, AM J SPORT MED, V43, P2208, DOI 10.1177/0363546515591257
  7. Edwards PK, 2014, J ORTHOP SPORT PHYS, V44, P102, DOI 10.2519/jospt.2014.5055
  8. Edwards PK, 2013, AM J SPORT MED, V41, P2314, DOI 10.1177/0363546513495637
  9. Gobbi RG, 2015, REV BRAS ORTOP, V45, P449
  10. Gomoll AH, 2017, AM J SPORT MED, V45, P1028, DOI 10.1177/0363546516681000
  11. Goyal D, 2013, ARTHROSCOPY, V29, P1872, DOI 10.1016/j.arthro.2013.07.271
  12. Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
  13. Hinckel BB, 2017, CLIN SPORT MED, V36, P525, DOI 10.1016/j.csm.2017.02.008
  14. Hoemann C, 2011, CARTILAGE, V2, P153, DOI 10.1177/1947603510397535
  15. Huang BJ, 2016, BIOMATERIALS, V98, P1, DOI 10.1016/j.biomaterials.2016.04.018
  16. Minas T, 2012, J BONE JOINT SURG BR, V94B, P141, DOI 10.1302/0301-620X.94B11.30679
  17. Moran CJ, 2014, J BONE JOINT SURG AM, V96A, P336, DOI 10.2106/JBJS.L.01329
  18. Niethammer TR, 2018, AM J SPORT MED, V46, P2414, DOI 10.1177/0363546518784593
  19. Ozmeric A, 2014, WORLD J ORTHOP, V5, P677, DOI 10.5312/wjo.v5.i5.677
  20. Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8
  21. Saris D, 2014, AM J SPORT MED, V42, P1384, DOI 10.1177/0363546514528093
  22. Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246